CBD for Crohn's Disease: Relieving Pain, Reducing Flare-ups
|
Time to read 6 min
Free delivery on orders over €59 🚚
|
Time to read 6 min
Crohn's disease is a chronic inflammatory bowel disease and can affect the entire gastrointestinal tract. Typical symptoms such as abdominal pain, chronic diarrhea, weight loss, and exhaustion significantly impair the quality of life of affected individuals.
The causes of the disease are still not fully understood, making treatment challenging. To naturally address the symptoms, many people are now placing great hope in cannabidiol (CBD). It not only helps to alleviate symptoms such as pain and digestive problems. It may even help to reduce the frequency of disease flare-ups.
In this article, we clarify which mechanisms of action of CBD in bowel diseases such as Crohn's disease could play a role and provide tips on the use of CBD products for acute flare-ups and for long-term treatment.
Conventional treatment for Crohn's disease is often associated with severe side effects - especially when medications are used over a long period. Since Crohn's disease is not curable, affected individuals seek alternatives that are also well-tolerated long-term, such as cannabinoids like CBD.
CBD can help to improve the quality of life of affected individuals by alleviating pain and reducing inflammation.
Research is currently also investigating whether CBD, through its immunomodulatory properties, could help to prevent disease flare-ups. The results here are not conclusive but are very promising.
Recommended Products
Crohn's disease, as a chronic inflammatory bowel disease (IBD), can affect the entire digestive tract, with the transition from the small to the large intestine often causing problems. The disease typically runs in episodes, meaning phases of severe symptoms alternate with relatively symptom-free periods.
The exact cause of Crohn's disease is still not fully understood. It is believed that a combination of genetic factors, an overreaction of the immune system, and environmental factors such as diet and stress play a role. In affected individuals, the immune system mistakenly attacks the body's own intestinal wall, leading to chronic inflammation.
The most common symptoms of Crohn's disease are abdominal pain and cramps, chronic diarrhea (sometimes with blood), loss of appetite, weight loss and malnutrition, as well as fatigue and exhaustion. In some cases, extraintestinal symptoms such as joint and skin inflammation or eye problems also occur.
Without adequate treatment, Crohn's disease can cause severe complications, including intestinal narrowing (stenosis), fistulas, or even bowel obstructions.
The therapy aims to alleviate symptoms (e.g., pain), reduce inflammation, and prevent flare-ups long-term. In addition to medications such as corticosteroids, immunomodulators, and biologics, surgical interventions (e.g., removal of intestinal sections) are used in severe cases.
Even though these therapies can now bring great relief to those affected, they naturally do not come without side effects. The interest in natural alternatives with fewer severe side effects is correspondingly high.
CBD (Cannabidiol) is a cannabinoid from the cannabis plant. Unlike other active ingredients from the cannabis group (e.g., THC/medical cannabis), it is not psychoactive and does not cause physical dependence. CBD interacts with the endocannabinoid system (ECS), which appears to play a crucial role in regulating inflammation and immune response in the gut. (1)
Research into the effectiveness of CBD is now quite extensive. Positive effects of CBD on the gut have been observed primarily through:
Anti-inflammatory properties: CBD interacts with CB2 receptors in the ECS, which have anti-inflammatory effects.
Pain relief: CBD interacts with TRPV1 receptors, which play a role in pain sensation.
Immunomodulation: Cannabidiol regulates overactive immune responses that can lead to inflammation.
Compared to conventional medications, CBD has significantly fewer side effects and is better tolerated long-term.
Property |
CBD |
Conventional Treatment |
|---|---|---|
Anti-inflammatory |
Acts specifically on CB2 receptors |
Biologics inhibit specific cytokines |
Pain relief |
Interaction with TRPV1 receptors |
Pain relievers such as paracetamol or opioids |
Immunomodulation |
Interaction with the endocannabinoid system |
Immunomodulators increase infection risk |
Side effects |
Minor, usually mild |
Frequent systemic side effects |
Application |
Oral (sublingual - oil, capsules) or rubbing in for abdominal pain |
Injections, infusions or tablets |
Long-term tolerability |
Promising |
Partly problematic with long-term use |
The research situation on CBD in Crohn's disease and other IBDs is still in an early stage, but it provides initial promising results:
For example, a 2017 study investigated the effect of CBD in 19 patients with Crohn's disease. The subjects received 10 mg of CBD twice daily or a placebo. CBD showed good tolerability, but only limited improvements in clinical remission. Nevertheless, the authors suspect a potential benefit in alleviating symptoms and refer to further research. (2)
The 2021 study "Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease" investigated the efficacy of CBD-rich cannabis oil in treating Crohn's disease. A randomized controlled trial over 8 weeks showed a significant improvement in clinical symptoms, and the tested individuals reported an increased general quality of life. (3)
Another study from 2024 examined how CBD affects the protective barrier of the stomach by strengthening so-called tight junction proteins, which are important for the stability of the stomach lining. Experiments showed that CBD can strengthen these connections between cells without changing their structure. This could indicate that CBD could also help in the long-term treatment of Crohn's disease and prevent flare-ups (4)
Although research results are not yet conclusive, CBD is already recognized as a valuable addition to conventional treatment methods for Crohn's disease. (5) CBD can help:
Pain relief for mild flare-ups: CBD can reduce abdominal pain without causing the side effects of strong painkillers.
Chronic inflammation: The anti-inflammatory properties of cannabidiol could help to curb inflammatory processes and strengthen the intestinal flora.
Stress reduction: CBD has a calming effect, can lower stress levels, and improve sleep. Since stress is suspected to worsen flare-ups, CBD can help here.
Appetite regulation : CBD products can help to gently increase appetite, thus helping to prevent weight loss and malnutrition.
To ensure maximum effectiveness, CBD should be consumed over a longer period. Start with a low dose (10-25 mg per day), which you can take, for example, as CBD drops under the tongue. Observe at what dose you perceive the desired effect. If undesirable side effects occur (e.g., dry mouth), reduce the dose slightly.
If you don't like the hemp taste or prefer a convenient on-the-go solution, CBD aroma sprays offer a good alternative. For acute abdominal pain, a gentle massage with a CBD balm can also help to relieve pain and make you feel generally more comfortable.
Customer feedback:
Even though CBD has very few side effects: Please consult your doctor before use, especially if you are already taking other medications.
CBD shows great potential as a natural supplement in the treatment of Crohn's disease. The current study situation on models and affected individuals is promising, but further research is still needed to understand the exact mechanisms.
It is certain that the consumption of CBD can greatly improve the quality of life for those affected - for example, through more restful sleep, reduced stress perception, and the natural increase in appetite and well-being. Before use, you should always consult a doctor, especially if you are already taking medication.
CBD can be individually adapted to your needs, symptoms, and daily life, making it the ideal supplement to conventional medicine for Crohn's disease.
Our customers' opinions:
Sources and Studies
¹ Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022). A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharmacol Toxicol, 130(4), 439-456.
² Naftali, T., Mechulam, R., Marii, A., Gabay, G., Stein, A., Bronshtain, M., Laish, I., Benjaminov, F., & Konikoff, FM. (2017). Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial. Dig Dis Sci, 62(6), 1615-1620.
³ Naftali, T., Bar-Lev Schleider, L., Almog, S., Meiri, D., & Konikoff, FM. (2021). Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial. J Crohns Colitis, 15(11), 1799-1806.
⁴ Stein, L., Vollstaedt, ML., & Amasheh, S. (2024). Cannabidiol Strengthening of Gastric Tight Junction Complexes Analyzed in an Improved Xenopus Oocyte Assay. Membranes (Basel), 14(1), 18.
⁵ Brown, K., Funk, K., Figueroa Barrientos, A., Bailey, A., Shrader, S., Feng, W., McClain, CJ., & Song, ZH. (2024). The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut. Cells, 13(19), 1618.